Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Portfolio Pulse from
Celularity Inc. announced that its strategic partner, Genting Berhad, has started construction on a new stem cell and regenerative medicine center in Bali, Indonesia. The facility will use Celularity's placenta-derived stem cells and is expected to begin operations by the end of 2026.
November 20, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Celularity's strategic partner, Genting Berhad, is building a new stem cell and regenerative medicine center in Bali, which will use Celularity's placenta-derived stem cells. This development could enhance Celularity's market presence in the Asia Pacific region.
The construction of a new facility by Genting Berhad, using Celularity's stem cells, indicates a potential increase in demand for Celularity's products. This could positively impact Celularity's market presence and revenue in the Asia Pacific region.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80